Intensified Glucose Lowering in Type 2 Diabetes: Time for a Reappraisal

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2010 Aug 6

PMID 20686748

Citations 46

Authors

J S Yudkin

B Richter

E A M Gale

Affiliations

Soon will be listed here.

Citing Articles

Smart Pharmaceutical Monitoring System With Personalized Medication Schedules and Self-Management Programs for Patients With Diabetes: Development and Evaluation Study.

Xiao J, Li M, Cai R, Huang H, Yu H, Huang L J Med Internet Res. 2025; 27:e56737.

PMID: 39933171 PMC: 11862767. DOI: 10.2196/56737.

Prevalence of Comorbidities among Patients with Type-2 Diabetes Mellitus in Saudi Population.

Sattar K, Karim S, Akram A, Alrashed F Pak J Med Sci. 2024; 40(8):1651-1657.

PMID: 39281229 PMC: 11395354. DOI: 10.12669/pjms.40.8.9003.

The Protective Effects of Eicosapentaenoic Acid for Stress-induced Accelerated Senescence in Vascular Endothelial Cells.

Kwon M, Jung H, Kang S, Lee S, Park J Int J Med Sci. 2023; 20(11):1479-1491.

PMID: 37790848 PMC: 10542193. DOI: 10.7150/ijms.85224.

[Integrating hypertension and diabetes management in primary health care settings: HEARTS as a toolIntegrando o manejo da hipertensão e do diabetes na atenção primária à saúde: uso do HEARTS como instrumento].

Flood D, Edwards E, Giovannini D, Ridley E, Rosende A, Herman W Rev Panam Salud Publica. 2022; 46:e213.

PMID: 36415785 PMC: 9673610. DOI: 10.26633/RPSP.2022.213.

Integrating hypertension and diabetes management in primary health care settings: HEARTS as a tool.

Flood D, Edwards E, Giovannini D, Ridley E, Rosende A, Herman W Rev Panam Salud Publica. 2022; 46:e150.

PMID: 36071915 PMC: 9440730. DOI: 10.26633/RPSP.2022.150.

References

Nathan D, Cleary P, Backlund J, Genuth S, Lachin J, Orchard T . Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005; 353(25):2643-53. PMC: 2637991. DOI: 10.1056/NEJMoa052187. View

Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J . Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007; 370(9602):1829-39. DOI: 10.1016/S0140-6736(07)61778-4. View

. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View

Yudkin J, Richter B, Gale E . Intensified glucose control in type 2 diabetes--whose agenda?. Lancet. 2010; 377(9773):1220-2. DOI: 10.1016/S0140-6736(10)61112-9. View

Vijan S, Hofer T, Hayward R . Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med. 1998; 127(9):788-95. DOI: 10.7326/0003-4819-127-9-199711010-00003. View

Hebert P, Moser M, Mayer J, Glynn R, Hennekens C . Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993; 153(5):578-81. View

. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967; 202(11):1028-34. View

Ray K, Seshasai S, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D . Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009; 373(9677):1765-72. DOI: 10.1016/S0140-6736(09)60697-8. View

Huang E, Zhang Q, Gandra N, Chin M, Meltzer D . The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med. 2008; 149(1):11-9. PMC: 2562733. DOI: 10.7326/0003-4819-149-1-200807010-00005. View

10.

Buskens E . Let's not turn elderly people into patients. Wanted: age adjusted outcomes. BMJ. 2009; 338:b1309. DOI: 10.1136/bmj.b1309. View

11.

Huang E, Brown S, Ewigman B, Foley E, Meltzer D . Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care. 2007; 30(10):2478-83. PMC: 2288662. DOI: 10.2337/dc07-0499. View

12.

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

13.

Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati F, Powe N . Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004; 141(6):421-31. DOI: 10.7326/0003-4819-141-6-200409210-00007. View

14.

Gigerenzer G . Making sense of health statistics. Bull World Health Organ. 2009; 87(8):567. PMC: 2733256. DOI: 10.2471/blt.09.069872. View

15.

. W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators. Lancet. 1980; 2(8191):379-85. View

16.

Skyler J, Bergenstal R, Bonow R, Buse J, Deedwania P, Gale E . Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of.... Circulation. 2008; 119(2):351-7. DOI: 10.1161/CIRCULATIONAHA.108.191305. View

17.

Kelly T, Bazzano L, Fonseca V, Thethi T, Reynolds K, He J . Systematic review: glucose control and cardiovascular disease in type 2 diabetes. Ann Intern Med. 2009; 151(6):394-403. DOI: 10.7326/0003-4819-151-6-200909150-00137. View

18.

Simmons R, Coleman R, Price H, Holman R, Khaw K, Wareham N . Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort. Diabetes Care. 2008; 32(4):708-13. PMC: 2660447. DOI: 10.2337/dc08-1918. View

19.

Law M, Morris J, Wald N . Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338:b1665. PMC: 2684577. DOI: 10.1136/bmj.b1665. View

20.

Yudkin J . How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. BMJ. 1993; 306(6888):1313-8. PMC: 1677709. DOI: 10.1136/bmj.306.6888.1313. View